These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17286793)

  • 1. Amisulpride augmentation after the failure of citalopram for depression: a case report.
    Carvalho AF; Nunes-Neto PR; Cavalcante JL; Oliveira Lima MC
    J Clin Pharm Ther; 2007 Feb; 32(1):97-9. PubMed ID: 17286793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive low-dose amisulpride in motor conversion disorder.
    Oulis P; Kokras N; Papadimitriou GN; Masdrakis VG
    Clin Neuropharmacol; 2009; 32(6):342-3. PubMed ID: 19952874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.
    Pardini M; Guida S; Primavera A; Krueger F; Cocito L; Gialloreti LE
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):282-6. PubMed ID: 21112746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
    Peritogiannis V; Goulia P; Pappas D; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2007 Apr; 27(2):235-7. PubMed ID: 17414262
    [No Abstract]   [Full Text] [Related]  

  • 7. [The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
    D'iakonov AL; Lobanova IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):61-6. PubMed ID: 23257758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.
    Admon R; Kaiser RH; Dillon DG; Beltzer M; Goer F; Olson DP; Vitaliano G; Pizzagalli DA
    Am J Psychiatry; 2017 Apr; 174(4):378-386. PubMed ID: 27771973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication augmentation after the failure of SSRIs for depression.
    Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
    N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case series.
    Miodownik C; Bergman J; Lerner PP; Kreinin A; Lerner V
    Clin Neuropharmacol; 2015; 38(1):26-9. PubMed ID: 25580923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study.
    Altamura AC; Dell'Osso B; Buoli M; Bosi M; Mundo E
    Int Clin Psychopharmacol; 2008 Jul; 23(4):198-202. PubMed ID: 18545057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
    Hermann D; Heinz A; Croissant B; Mann K
    Pharmacopsychiatry; 2004 Mar; 37(2):90-2. PubMed ID: 15048618
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
    Maina G; Vitalucci A; Gandolfo S; Bogetto F
    J Clin Psychiatry; 2002 Jan; 63(1):38-43. PubMed ID: 11838624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpigmentation with amisulpride.
    Mendhekar DN
    Aust N Z J Psychiatry; 2009 Jan; 43(1):88. PubMed ID: 19086350
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic mechanism of antidepressant action in depressed patients.
    Willner P; Hale AS; Argyropoulos S
    J Affect Disord; 2005 May; 86(1):37-45. PubMed ID: 15820269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.